BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8041394)

  • 21. Disease course and prognostic factors of progressive muscular atrophy.
    Visser J; van den Berg-Vos RM; Franssen H; van den Berg LH; Wokke JH; de Jong JM; Holman R; de Haan RJ; de Visser M
    Arch Neurol; 2007 Apr; 64(4):522-8. PubMed ID: 17420313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Calpain-3 gene defect causing limb gird muscular dystrophy in a Hungarian family].
    Horváth R; Walter MC; Lochmüller H; Hübner A; Karcagi V; Pikó H; Timár L; Komoly S
    Ideggyogy Sz; 2005 Jan; 58(1-2):52-8. PubMed ID: 15884399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing functional outcomes of children with muscular dystrophy and scoliosis: the Muscular Dystrophy Spine Questionnaire.
    Wright JG; Smith PL; Owen JL; Fehlings D
    J Pediatr Orthop; 2008 Dec; 28(8):840-5. PubMed ID: 19034175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A clinical trial of creatine monohydrate in muscular dystrophy patients].
    Matsumura T; Yokoe M; Nakamori M; Hattori N; Saito T; Nozaki S; Fujimura H; Shinno S
    Rinsho Shinkeigaku; 2004 Oct; 44(10):661-6. PubMed ID: 15568480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spinal muscular atrophy: survival pattern and functional status.
    Chung BH; Wong VC; Ip P
    Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease.
    Van der Beek NA; Hagemans ML; Reuser AJ; Hop WC; Van der Ploeg AT; Van Doorn PA; Wokke JH
    Neuromuscul Disord; 2009 Feb; 19(2):113-7. PubMed ID: 19084399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung and respiratory muscle function in limb girdle muscular dystrophy.
    Stübgen JP; Ras GJ; Schultz CM; Crowther G
    Thorax; 1994 Jan; 49(1):61-5. PubMed ID: 8153942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progression of motor impairment and disability in Parkinson disease: a population-based study.
    Alves G; Wentzel-Larsen T; Aarsland D; Larsen JP
    Neurology; 2005 Nov; 65(9):1436-41. PubMed ID: 16275832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Problem-focused coping and satisfaction with activities of daily living in individuals with muscular dystrophy and postpolio syndrome.
    Nätterlund B; Ahlström G
    Scand J Caring Sci; 1999; 13(1):26-32. PubMed ID: 10476191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional independence after major abdominal surgery in the elderly.
    Lawrence VA; Hazuda HP; Cornell JE; Pederson T; Bradshaw PT; Mulrow CD; Page CP
    J Am Coll Surg; 2004 Nov; 199(5):762-72. PubMed ID: 15501119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pain among children and adolescents: restrictions in daily living and triggering factors.
    Roth-Isigkeit A; Thyen U; Stöven H; Schwarzenberger J; Schmucker P
    Pediatrics; 2005 Feb; 115(2):e152-62. PubMed ID: 15687423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A family of autosomal dominant facio-limb-girdle muscular dystrophy].
    Takao S; Kira J; Kohtake N; Yoshimura T; Goto I
    Fukuoka Igaku Zasshi; 1996 Dec; 87(12):278-82. PubMed ID: 9011111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Locomotor disability in bancroftian filarial lymphoedema patients.
    Das LK; Pani SP; Vinod SK
    J Commun Dis; 2008 Mar; 40(1):13-9. PubMed ID: 19127664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A longitudinal analysis of physical functional disability over the course of juvenile idiopathic arthritis.
    Magni-Manzoni S; Pistorio A; Labò E; Viola S; Garcia-Munitis P; Panigada S; Visconti C; Buoncompagni A; Martini A; Ravelli A
    Ann Rheum Dis; 2008 Aug; 67(8):1159-64. PubMed ID: 17965116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serial manual muscle testing in Duchenne muscular dystrophy.
    Kilmer DD; Abresch RT; Fowler WM
    Arch Phys Med Rehabil; 1993 Nov; 74(11):1168-71. PubMed ID: 8239956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular approaches to therapy for Duchenne and limb-girdle muscular dystrophy.
    Stedman HH
    Curr Opin Mol Ther; 2001 Aug; 3(4):350-6. PubMed ID: 11525558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of the progression of functional disability in patients with ankylosing spondylitis.
    Ward MM
    J Rheumatol; 2002 Jul; 29(7):1420-5. PubMed ID: 12136900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum CPK activities in long term follow up cases of progressive muscular dystrophy of Duchenne's type -with special reference to the course of disability and body weight (author's transl)].
    Konagaya M; Kohno K; Takayanagi T; Sobue I
    Rinsho Shinkeigaku; 1981 Feb; 21(2):150-7. PubMed ID: 7261497
    [No Abstract]   [Full Text] [Related]  

  • 39. Profiles of neuromuscular diseases. Limb-girdle syndromes.
    McDonald CM; Johnson ER; Abresch RT; Carter GT; Fowler WM; Kilmer DD
    Am J Phys Med Rehabil; 1995; 74(5 Suppl):S117-30. PubMed ID: 7576419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rehabilitation management of muscular dystrophy and related disorders: I. The role of exercise.
    Fowler WM; Taylor M
    Arch Phys Med Rehabil; 1982 Jul; 63(7):319-21. PubMed ID: 7092533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.